Matches in DBpedia 2016-04 for { ?s ?p "DOV-102,677 is a psychoactive drug being developed by Merck and is currently in clinical trials. It is a so-called triple reuptake inhibitor (TRI), or serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI)."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- DOV-102,677 comment "DOV-102,677 is a psychoactive drug being developed by Merck and is currently in clinical trials. It is a so-called triple reuptake inhibitor (TRI), or serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI).".
- Q5205903 comment "DOV-102,677 is a psychoactive drug being developed by Merck and is currently in clinical trials. It is a so-called triple reuptake inhibitor (TRI), or serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI).".